Do endothelial progenitor cells modify our strategy to treat risk factors?
Үндсэн зохиолчид: | Tousoulis, D, Andreou, I, Antoniades, C, Siasos, G, Stougiannos, P, Trikas, A, Stefanadis, C |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2011
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Do endothelial progenitor cells modify our strategy to treat risk factors?
-н: Tousoulis, D, зэрэг
Хэвлэсэн: (2010) -
Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
-н: Andreou, I, зэрэг
Хэвлэсэн: (2006) -
Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
-н: Tousoulis, D, зэрэг
Хэвлэсэн: (2008) -
Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.
-н: Bakogiannis, C, зэрэг
Хэвлэсэн: (2012) -
The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development.
-н: Briasoulis, A, зэрэг
Хэвлэсэн: (2011)